
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.2B | $1.5B | $1.9B | $2.5B | $3B | |
Revenue Growth (YoY) | 2.08% | 21.91% | 30.5% | 31.42% | 18.38% | |
Cost of Revenues | $963.6M | $1.3B | $1.6B | $1.7B | $2B | |
Gross Profit | $232M | $147M | $287M | $813M | $1B | |
Gross Profit Margin | 19.4% | 10.09% | 15.09% | 32.52% | 34.09% | |
R&D Expenses | $13M | $14.2M | $21.6M | $42.4M | $79.4M | |
Selling, General & Admin | $60.4M | $66.9M | $96.9M | $183.6M | $290.3M | |
Other Inc / (Exp) | -- | -$765K | $2.4M | $34.7M | $22M | |
Operating Expenses | $73.5M | $81.1M | $118.5M | $225.9M | $369.7M | |
Operating Income | $158.5M | $65.9M | $168.5M | $587.1M | $639.1M | |
Net Interest Expenses | $502K | $34K | $1.8M | $13.8M | $13.1M | |
EBT. Incl. Unusual Items | $158M | $65.1M | $169.1M | $608M | $648M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $33.7M | $14.2M | $47.8M | $111.8M | $130.8M | |
Net Income to Company | $124.3M | $50.9M | $121.3M | $496.2M | $517.2M | |
Minority Interest in Earnings | -- | -- | -$2.4M | -$190M | -$8.1M | |
Net Income to Common Excl Extra Items | $124.3M | $50.9M | $118.9M | $306.2M | $509.2M | |
Basic EPS (Cont. Ops) | -- | -- | $0.02 | $3.97 | $3.55 | |
Diluted EPS (Cont. Ops) | -- | -- | $0.02 | $3.37 | $3.47 | |
Weighted Average Basic Share | $41.9M | $41.9M | $45.9M | $77.1M | $143.5M | |
Weighted Average Diluted Share | $41.9M | $41.9M | $145.9M | $147.3M | $149.3M | |
EBITDA | $175.3M | $76.3M | $175.5M | $626.2M | $674.5M | |
EBIT | $158.5M | $65.1M | $170.9M | $621.8M | $661.1M | |
Revenue (Reported) | $1.2B | $1.5B | $1.9B | $2.5B | $3B | |
Operating Income (Reported) | $158.5M | $65.9M | $168.5M | $587.1M | $639.1M | |
Operating Income (Adjusted) | $158.5M | $65.1M | $170.9M | $621.8M | $661.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $439.8M | $518.4M | $736.5M | $924.3M | |
Revenue Growth (YoY) | -- | -- | 17.87% | 42.08% | 25.5% | |
Cost of Revenues | -- | $400.9M | $428.1M | $396M | $618.7M | |
Gross Profit | -- | $39M | $90.3M | $340.5M | $305.7M | |
Gross Profit Margin | -- | 8.86% | 17.42% | 46.23% | 33.07% | |
R&D Expenses | -- | $3.6M | $8.3M | $13.1M | $23.6M | |
Selling, General & Admin | -- | $27.8M | $41.4M | $56.7M | $86.8M | |
Other Inc / (Exp) | -- | -- | -- | $16.2M | $23.8M | |
Operating Expenses | -- | $31.4M | $49.7M | $69.8M | $114.8M | |
Operating Income | -- | $7.6M | $40.6M | $270.7M | $190.9M | |
Net Interest Expenses | -- | -- | $3M | $3.8M | $16.1M | |
EBT. Incl. Unusual Items | -- | $7.1M | $40.1M | $283.1M | $198.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | $1.4M | $12.5M | $59.9M | $40.8M | |
Net Income to Company | -- | -- | $27.5M | $223.2M | $157.8M | |
Minority Interest in Earnings | -- | -- | -$2.4M | -$18M | -$1M | |
Net Income to Common Excl Extra Items | -- | $5.8M | $25.1M | $205.2M | $156.8M | |
Basic EPS (Cont. Ops) | -- | -$1.08 | $0.02 | $1.48 | $1.08 | |
Diluted EPS (Cont. Ops) | -- | -$1.08 | $0.02 | $1.48 | $1.05 | |
Weighted Average Basic Share | -- | $41.9M | $45.9M | $140.8M | $144.9M | |
Weighted Average Diluted Share | -- | $41.9M | $45.9M | $147.7M | $149.7M | |
EBITDA | -- | $8.1M | $44M | $288.1M | $206.1M | |
EBIT | -- | $6.8M | $43M | $286.9M | $201M | |
Revenue (Reported) | -- | $439.8M | $518.4M | $736.5M | $924.3M | |
Operating Income (Reported) | -- | $7.6M | $40.6M | $270.7M | $190.9M | |
Operating Income (Adjusted) | -- | $6.8M | $43M | $286.9M | $201M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $1.5B | $1.9B | $2.5B | $3B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | $1.6B | $1.7B | $2B | |
Gross Profit | -- | -- | $287M | $813M | $1B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | $21.6M | $38.8M | $79.4M | |
Selling, General & Admin | -- | -- | $96.9M | $187.2M | $290.3M | |
Other Inc / (Exp) | -- | -- | -- | $20.4M | $26.6M | |
Operating Expenses | -- | -- | $118.5M | $218.7M | $369.7M | |
Operating Income | -- | -- | $168.5M | $594.3M | $639.1M | |
Net Interest Expenses | -- | -- | $1.8M | $6.7M | $17.7M | |
EBT. Incl. Unusual Items | -- | -- | $169.1M | $608M | $648M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | $47.8M | $111.8M | $130.8M | |
Net Income to Company | -- | -- | $121.3M | $496.2M | $517.2M | |
Minority Interest in Earnings | -- | -- | -$2.4M | -$190M | -$8.1M | |
Net Income to Common Excl Extra Items | -- | -- | $118.9M | $306.2M | $509.2M | |
Basic EPS (Cont. Ops) | -- | -- | $0.02 | $3.23 | $3.54 | |
Diluted EPS (Cont. Ops) | -- | -- | $0.02 | $3.13 | $3.48 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | $175.5M | $626.2M | $674.5M | |
EBIT | -- | -- | $170.9M | $621.8M | $661.1M | |
Revenue (Reported) | -- | $1.5B | $1.9B | $2.5B | $3B | |
Operating Income (Reported) | -- | -- | $168.5M | $594.3M | $639.1M | |
Operating Income (Adjusted) | -- | -- | $170.9M | $621.8M | $661.1M |
Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
---|---|---|---|---|---|---|
Revenue | $777.4M | $1.9B | $2.5B | $3B | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $704.7M | $1.6B | $1.7B | $2B | -- | |
Gross Profit | $72.7M | $287M | $813M | $1B | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $7.2M | $21.6M | $38.8M | $79.4M | -- | |
Selling, General & Admin | $40.8M | $96.9M | $187.2M | $290.3M | -- | |
Other Inc / (Exp) | -- | -- | $20.4M | $26.6M | -- | |
Operating Expenses | $48M | $118.5M | $218.7M | $369.7M | -- | |
Operating Income | $24.7M | $168.5M | $594.3M | $639.1M | -- | |
Net Interest Expenses | $91K | $4.3M | $6.9M | $19.7M | -- | |
EBT. Incl. Unusual Items | $24.2M | $169.1M | $608M | $648M | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $5.8M | $47.8M | $111.8M | $130.8M | -- | |
Net Income to Company | -- | $121.3M | $496.2M | $517.2M | -- | |
Minority Interest in Earnings | -- | -$2.4M | -$190M | -$8.1M | -- | |
Net Income to Common Excl Extra Items | $18.3M | $118.9M | $306.2M | $509.2M | -- | |
Basic EPS (Cont. Ops) | -$0.78 | $0.02 | $3.23 | $3.54 | -- | |
Diluted EPS (Cont. Ops) | -$0.78 | $0.02 | $3.13 | $3.48 | -- | |
Weighted Average Basic Share | $83.8M | $175.5M | $311M | $574.1M | -- | |
Weighted Average Diluted Share | $83.8M | $175.5M | $589M | $597M | -- | |
EBITDA | $26.4M | $175.5M | $626.2M | $674.5M | -- | |
EBIT | $23.9M | $170.9M | $621.8M | $661.1M | -- | |
Revenue (Reported) | $777.4M | $1.9B | $2.5B | $3B | -- | |
Operating Income (Reported) | $24.7M | $168.5M | $594.3M | $639.1M | -- | |
Operating Income (Adjusted) | $23.9M | $170.9M | $621.8M | $661.1M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $190.6M | $29.1M | $130M | $474.1M | $766.1M | |
Short Term Investments | $27.4M | $9.3M | -- | -- | -- | |
Accounts Receivable, Net | $121.4M | $168.3M | $271.2M | $382.7M | $472.5M | |
Inventory | $84.5M | $172.2M | $138.1M | $201.7M | $209.4M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $12.6M | $42.8M | $35.1M | $187.2M | $88.5M | |
Total Current Assets | $583.3M | $714.1M | $872.3M | $1.8B | $2.2B | |
Property Plant And Equipment | $5M | $7.4M | $7.3M | $9.2M | $60.4M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $265.2M | $265.2M | $265.2M | $265.2M | $371M | |
Other Intangibles | $11M | $2.5M | $1.3M | $1.5M | $53.2M | |
Other Long-Term Assets | $16.5M | $28.1M | $273.7M | $36.3M | $51.1M | |
Total Assets | $881M | $1B | $1.4B | $2.5B | $3.2B | |
Accounts Payable | $231.5M | $266.6M | $211.4M | $456.6M | $585.3M | |
Accrued Expenses | $35.6M | $26.2M | $59.8M | $82.4M | $97M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $18.1M | $63.4M | $47.6M | $123.1M | $104.1M | |
Total Current Liabilities | $391.4M | $473.4M | $507.4M | $891.5M | $1B | |
Long-Term Debt | -- | -- | $147.1M | $144M | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $424.9M | $1B | $934.8M | $1.5B | $1.6B | |
Common Stock | -- | -- | $15K | $14K | $15K | |
Other Common Equity Adj | -- | -- | -- | $17K | -$298K | |
Common Equity | $456M | -$3M | -$3.1B | $961M | $1.6B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | $3.6B | $31M | -- | |
Total Equity | $456M | -$3M | $484.9M | $992M | $1.6B | |
Total Liabilities and Equity | $881M | $1B | $1.4B | $2.5B | $3.2B | |
Cash and Short Terms | $218M | $38.4M | $130M | $474.1M | $766.1M | |
Total Debt | -- | -- | $147.1M | $147.7M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | $29.1M | $130M | $474.1M | $766.1M | |
Short Term Investments | -- | $9.3M | -- | -- | -- | |
Accounts Receivable, Net | -- | $168.3M | $271.2M | $382.7M | $472.5M | |
Inventory | -- | $172.2M | $138.1M | $201.7M | $209.4M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | $42.8M | $35.1M | $187.2M | $88.5M | |
Total Current Assets | -- | $714.1M | $872.3M | $1.8B | $2.2B | |
Property Plant And Equipment | -- | $7.4M | $7.3M | $9.2M | $60.4M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | $265.2M | $265.2M | $265.2M | $371M | |
Other Intangibles | -- | $2.5M | $1.3M | $1.5M | $53.2M | |
Other Long-Term Assets | -- | $28.1M | $273.7M | $36.3M | $51.1M | |
Total Assets | -- | $1B | $1.4B | $2.5B | $3.2B | |
Accounts Payable | -- | $266.6M | $211.4M | $456.6M | $585.3M | |
Accrued Expenses | -- | $26.2M | $59.8M | $82.4M | $97M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | $63.4M | $47.6M | $123.1M | $104.1M | |
Total Current Liabilities | -- | $473.4M | $507.4M | $891.5M | $1B | |
Long-Term Debt | -- | -- | $147.1M | $144M | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | $1B | $934.8M | $1.5B | $1.6B | |
Common Stock | -- | -- | $15K | $14K | $15K | |
Other Common Equity Adj | -- | -- | -- | $17K | -$298K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | $3.6B | $31M | -- | |
Total Equity | -- | -$3M | $484.9M | $992M | $1.6B | |
Total Liabilities and Equity | -- | $1B | $1.4B | $2.5B | $3.2B | |
Cash and Short Terms | -- | $38.4M | $130M | $474.1M | $766.1M | |
Total Debt | -- | -- | $147.1M | $147.7M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $124.3M | $50.9M | $121.3M | $496.2M | $517.2M | |
Depreciation & Amoritzation | $16.8M | $11.1M | $4.6M | $4.4M | $13.4M | |
Stock-Based Compensation | $4.3M | $3M | $32M | $56.8M | $118.9M | |
Change in Accounts Receivable | -$47.8M | -$191.1M | -$167.3M | -$338.5M | -$148.5M | |
Change in Inventories | -$23.3M | -$87.7M | $25.1M | -$61M | -$3M | |
Cash From Operations | $94.3M | -$147.1M | $107.7M | $429M | $655.8M | |
Capital Expenditures | $3M | $5.9M | $3.2M | $6.7M | $33.9M | |
Cash Acquisitions | -- | -- | -- | -- | -$152.2M | |
Cash From Investing | -$3M | -$5.8M | -$3.2M | -$6.7M | -$186.1M | |
Dividends Paid (Ex Special Dividend) | -$331.4M | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | $170M | -- | -- | |
Long-Term Debt Repaid | -- | -- | -$20M | -- | -$150M | |
Repurchase of Common Stock | -- | -- | -$693.8M | -$552M | -- | |
Other Financing Activities | $427.7M | -$8.7M | -$153.6M | -$78.3M | -$27.6M | |
Cash From Financing | $96.3M | -$8.7M | -$3.6M | -$78.3M | -$177.6M | |
Beginning Cash (CF) | $3M | $190.6M | $29.1M | $130M | $474.1M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $187.6M | -$161.5M | $100.9M | $344M | $292M | |
Ending Cash (CF) | $190.6M | $29.1M | $130M | $474.1M | $766.1M | |
Levered Free Cash Flow | $91.3M | -$153M | $104.5M | $422.3M | $621.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | $27.5M | $223.2M | $157.8M | |
Depreciation & Amoritzation | -- | -- | $1M | $1.2M | $5.1M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | $35.3M | $111.5M | $237.3M | |
Capital Expenditures | -- | -- | $530K | $2.8M | $10.1M | |
Cash Acquisitions | -- | -- | -- | -- | -$7.5M | |
Cash From Investing | -- | -- | -$530K | -$2.8M | -$17.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -$20M | $2.8M | -$147.2M | |
Repurchase of Common Stock | -- | -- | -$693.8M | -- | -- | |
Other Financing Activities | -- | -- | -$154.9M | -$5.3M | -- | |
Cash From Financing | -- | -- | -$4.8M | -$2.4M | -$147.2M | |
Beginning Cash (CF) | -- | -- | $100.1M | $367.8M | $693.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | $29.9M | $106.2M | $72.6M | |
Ending Cash (CF) | -- | -- | $130M | $474.1M | $766.1M | |
Levered Free Cash Flow | -- | -- | $34.8M | $108.7M | $227.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | $121.3M | $496.2M | $517.2M | |
Depreciation & Amoritzation | -- | -- | $4.6M | $4.4M | $13.4M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -$147.1M | $107.7M | $429M | $655.8M | |
Capital Expenditures | -- | -- | $3.2M | $6.7M | $33.9M | |
Cash Acquisitions | -- | -- | -- | -- | -$152.2M | |
Cash From Investing | -- | -- | -$3.2M | -$6.7M | -$186.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -$150M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -$153.6M | -- | -$27.6M | |
Cash From Financing | -- | -- | -$3.6M | -$78.3M | -$177.6M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | $100.9M | $344M | $292M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | $104.5M | $422.3M | $621.9M |
Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | $121.3M | $496.2M | $517.2M | -- | |
Depreciation & Amoritzation | -- | $4.6M | $4.4M | $13.4M | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | $107.7M | $429M | $655.8M | -- | |
Capital Expenditures | -- | $3.2M | $6.7M | $33.9M | -- | |
Cash Acquisitions | -- | -- | -- | -$152.2M | -- | |
Cash From Investing | -- | -$3.2M | -$6.7M | -$186.1M | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -$20M | -- | -$150M | -- | |
Repurchase of Common Stock | -- | -$693.8M | -$552M | -- | -- | |
Other Financing Activities | -- | -$153.6M | -$78.3M | -$27.6M | -- | |
Cash From Financing | -- | -$3.6M | -$78.3M | -$177.6M | -- | |
Beginning Cash (CF) | -- | $244.5M | $1.2B | $2.2B | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | $100.9M | $344M | $292M | -- | |
Ending Cash (CF) | -- | $345.4M | $1.6B | $2.5B | -- | |
Levered Free Cash Flow | -- | $104.5M | $422.3M | $621.9M | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.